Kolexia
Derumeaux-Burel Helene
Santé publique
Hôpital Hôtel-Dieu Saint-Jacques
Toulouse, France
54 Activités
2 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Thrombopénie Purpura thrombopénique idiopathique Sclérodermie systémique Sclérose Anémie Démence Accident vasculaire cérébral Maladie de Parkinson

Industries

Roche
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Influence of deprivation on hospital care pathways and costs for people with ischaemic stroke: A trajectory modelling study.
Annals of physical and rehabilitation medicine   25 octobre 2023
Mechanical Thrombectomy with Intravenous Thrombolysis versus Thrombolysis Alone for the Treatment of Stroke: A Systematic Review of Economic Evaluations.
Journal of vascular and interventional radiology : JVIR   17 juin 2023
Determinants of Resting Energy Expenditure in Very Old Nursing Home Residents.
The journal of nutrition, health & aging   28 septembre 2022
Cost-effectiveness analysis of vaginal misoprostol versus dinoprostone pessary: A non-inferiority large randomized controlled trial in France.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics   19 novembre 2021
The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT).
The journal of prevention of Alzheimer's disease   01 novembre 2021
Validation of Discharge Diagnosis of Sickle Cell Disease Vaso-Occlusive Episodes in the French Hospital Electronic Database.
Clinical epidemiology   13 août 2021
Assessment of the Accuracy of Using Codes to Identify Systemic Sclerosis.
Clinical epidemiology   08 décembre 2020
Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age: A Retrospective Monocentric Cohort Study.
Drugs & aging   04 novembre 2020
Profil d’effets indésirables du pyrazinamide en traitement de la tuberculose chez le sujet âgé de plus de 75 ans
21es Journées Nationales d’Infectiologie   01 septembre 2020
ASSESSMENT OF THE ACCURACY OF USING ICD-10 CODES TO IDENTIFY SYSTEMIC SCLEROSIS
Journal of scleroderma and related disorders Congress 2020   07 mai 2020